General Information of the Compound
Compound ID |
CP0452014
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
8-[4-[[(2S,5R)-5-[(R)-hydroxy(phenyl)methyl]pyrrolidin-2-yl]methyl]benzoyl]-3,3-dimethyl-2-oxa-8-azaspiro[4.5]decan-1-one
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C29H36N2O4
|
||||||||||||||||||
Molecular Weight |
476.617
|
||||||||||||||||||
Canonical SMILES |
CC1(C)CC2(CCN(CC2)C(=O)c2ccc(C[C@@H]3CC[C@@H](N3)[C@H](O)c3ccccc3)cc2)C(=O)O1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C29H36N2O4/c1-28(2)19-29(27(34)35-28)14-16-31(17-15-29)26(33)22-10-8-20(9-11-22)18-23-12-13-24(30-23)25(32)21-6-4-3-5-7-21/h3-11,23-25,30,32H,12-19H2,1-2H3/t23-,24+,25+/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
ZXBAVROPOWOIGN-ISJGIBHGSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01179, Beta-1 adrenergic receptor
Protein ID: PT01494, Beta-2 adrenergic receptor
Protein ID: PT01493, Beta-3 adrenergic receptor